HK1120424A1 - Carbazole derivatives as functional 5-ht6 ligands - Google Patents
Carbazole derivatives as functional 5-ht6 ligandsInfo
- Publication number
- HK1120424A1 HK1120424A1 HK08113183.2A HK08113183A HK1120424A1 HK 1120424 A1 HK1120424 A1 HK 1120424A1 HK 08113183 A HK08113183 A HK 08113183A HK 1120424 A1 HK1120424 A1 HK 1120424A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- carbazole derivatives
- receptor
- ligands
- functional
- stereoisomers
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/94—[b, c]- or [b, d]-condensed containing carbocyclic rings other than six-membered
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Hematology (AREA)
- Child & Adolescent Psychology (AREA)
- Vascular Medicine (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Nutrition Science (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
- Indole Compounds (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Photoreceptors In Electrophotography (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1504CH2005 | 2005-10-19 | ||
PCT/IN2006/000195 WO2007046111A1 (en) | 2005-10-19 | 2006-06-09 | Carbazole derivatives as functional 5-ht6 ligands |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1120424A1 true HK1120424A1 (en) | 2009-04-03 |
Family
ID=37054637
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK08113183.2A HK1120424A1 (en) | 2005-10-19 | 2008-12-03 | Carbazole derivatives as functional 5-ht6 ligands |
Country Status (24)
Country | Link |
---|---|
US (1) | US8143303B2 (pt) |
EP (1) | EP1948166B1 (pt) |
JP (1) | JP2009512681A (pt) |
KR (1) | KR101125820B1 (pt) |
CN (1) | CN101291670B (pt) |
AT (1) | ATE485040T1 (pt) |
AU (1) | AU2006305502B2 (pt) |
BR (1) | BRPI0619308A2 (pt) |
CA (1) | CA2626646C (pt) |
CY (1) | CY1111560T1 (pt) |
DE (1) | DE602006017722D1 (pt) |
DK (1) | DK1948166T3 (pt) |
EA (1) | EA014694B1 (pt) |
ES (1) | ES2354455T3 (pt) |
HK (1) | HK1120424A1 (pt) |
HR (1) | HRP20110041T1 (pt) |
NO (1) | NO341252B1 (pt) |
NZ (1) | NZ567865A (pt) |
PL (1) | PL1948166T3 (pt) |
PT (1) | PT1948166E (pt) |
RS (1) | RS51627B (pt) |
SI (1) | SI1948166T1 (pt) |
WO (1) | WO2007046111A1 (pt) |
ZA (1) | ZA200803118B (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013055386A2 (en) * | 2011-10-03 | 2013-04-18 | The University Of Utah Research Foundation | Application of 5-ht6 receptor antagonists for the alleviation of cognitive deficits of down syndrome |
CN106045972B (zh) * | 2016-06-03 | 2018-11-16 | 中山大学 | 咔唑-利凡斯的明二联体及其药物组合物和应用 |
CN106749184B (zh) * | 2016-11-15 | 2020-07-17 | 中山大学 | 8-氨基喹啉-羟基咔唑杂联体,其制备方法及其药物组合物 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1149078T3 (da) * | 1998-12-11 | 2006-07-10 | Univ Virginia Commonwealth | Selektive 5-HT6-receptorligander |
JP2005508349A (ja) * | 2001-10-09 | 2005-03-31 | ファルマシア アンド アップジョン カンパニー リミティド ライアビリティー カンパニー | 5−ht6受容体リガンドとしてのアリールスルホニル置換されたテトラヒドロ−およびヘキサヒドロ−カルバゾール |
-
2006
- 2006-06-09 US US12/083,707 patent/US8143303B2/en not_active Expired - Fee Related
- 2006-06-09 KR KR1020087010404A patent/KR101125820B1/ko active IP Right Grant
- 2006-06-09 ES ES06766266T patent/ES2354455T3/es active Active
- 2006-06-09 PT PT06766266T patent/PT1948166E/pt unknown
- 2006-06-09 CA CA2626646A patent/CA2626646C/en not_active Expired - Fee Related
- 2006-06-09 PL PL06766266T patent/PL1948166T3/pl unknown
- 2006-06-09 SI SI200630873T patent/SI1948166T1/sl unknown
- 2006-06-09 DK DK06766266.8T patent/DK1948166T3/da active
- 2006-06-09 AU AU2006305502A patent/AU2006305502B2/en not_active Ceased
- 2006-06-09 EP EP06766266A patent/EP1948166B1/en active Active
- 2006-06-09 CN CN2006800390082A patent/CN101291670B/zh not_active Expired - Fee Related
- 2006-06-09 WO PCT/IN2006/000195 patent/WO2007046111A1/en active Application Filing
- 2006-06-09 NZ NZ567865A patent/NZ567865A/en not_active IP Right Cessation
- 2006-06-09 AT AT06766266T patent/ATE485040T1/de active
- 2006-06-09 BR BRPI0619308-0A patent/BRPI0619308A2/pt not_active Application Discontinuation
- 2006-06-09 EA EA200801114A patent/EA014694B1/ru not_active IP Right Cessation
- 2006-06-09 DE DE602006017722T patent/DE602006017722D1/de active Active
- 2006-06-09 JP JP2008536206A patent/JP2009512681A/ja active Pending
- 2006-06-09 RS RS20110017A patent/RS51627B/en unknown
-
2008
- 2008-04-09 ZA ZA2008/03118A patent/ZA200803118B/en unknown
- 2008-04-09 NO NO20081739A patent/NO341252B1/no not_active IP Right Cessation
- 2008-12-03 HK HK08113183.2A patent/HK1120424A1/xx not_active IP Right Cessation
-
2011
- 2011-01-20 CY CY20111100064T patent/CY1111560T1/el unknown
- 2011-01-20 HR HR20110041T patent/HRP20110041T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
NO20081739L (no) | 2008-07-09 |
CA2626646C (en) | 2011-03-01 |
CA2626646A1 (en) | 2007-04-26 |
HRP20110041T1 (hr) | 2011-02-28 |
ZA200803118B (en) | 2011-11-30 |
NO341252B1 (no) | 2017-09-25 |
CN101291670B (zh) | 2012-07-04 |
EA200801114A1 (ru) | 2009-02-27 |
EA014694B1 (ru) | 2010-12-30 |
ATE485040T1 (de) | 2010-11-15 |
EP1948166B1 (en) | 2010-10-20 |
SI1948166T1 (sl) | 2011-02-28 |
NZ567865A (en) | 2010-07-30 |
KR101125820B1 (ko) | 2012-03-28 |
PT1948166E (pt) | 2011-01-19 |
AU2006305502A1 (en) | 2007-04-26 |
BRPI0619308A2 (pt) | 2013-03-05 |
AU2006305502B2 (en) | 2009-11-26 |
RS51627B (en) | 2011-08-31 |
CN101291670A (zh) | 2008-10-22 |
DE602006017722D1 (de) | 2010-12-02 |
CY1111560T1 (el) | 2015-10-07 |
DK1948166T3 (da) | 2011-01-31 |
EP1948166A1 (en) | 2008-07-30 |
US8143303B2 (en) | 2012-03-27 |
JP2009512681A (ja) | 2009-03-26 |
US20100189646A1 (en) | 2010-07-29 |
KR20080064848A (ko) | 2008-07-09 |
PL1948166T3 (pl) | 2011-04-29 |
WO2007046111A1 (en) | 2007-04-26 |
ES2354455T3 (es) | 2011-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL1888541T3 (pl) | Związki benzo[d]izoksazol-3-iloaminy i ich zastosowanie jako ligandów receptora waniloidowego | |
WO2006132914A3 (en) | Cyclobutyl amine derivatives | |
IL190654A (en) | Methods of Methyl-Sulfonamido-Propanamido, Processes for Preparation and Medicines Containing Them | |
GB0510141D0 (en) | Novel compounds B3 | |
TW200510301A (en) | Novel compounds | |
TW200510303A (en) | Novel compounds | |
TW200740814A (en) | Compounds | |
PT1877367E (pt) | Derivados do acetileno | |
HK1116796A1 (en) | Aminoaryl sulphonamide derivatives as functional 5-ht6 ligands | |
IL191751A0 (en) | Pyrrolo[2,3-c]pyridine derivatives | |
WO2007150010A3 (en) | Cyclopropyl amine derivatives as histamin h3 receptor modulators | |
WO2007021711A3 (en) | Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands | |
TW200738611A (en) | 9-Chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments | |
MX2008002158A (es) | Derivados de azinil-3-sulfonilindazol como ligandos de 5-hidroxitriptamina-6. | |
DK2155674T3 (da) | Aminoalkoxy-aryl-sulfonamidforbindelser og anvendelse heraf som 5-HT6-ligander | |
HK1120424A1 (en) | Carbazole derivatives as functional 5-ht6 ligands | |
TW200631952A (en) | Benzdioxan piperazine derivatives with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sites | |
MX2009005242A (es) | Derivados de 3-(hetero)arilisoquinolinamida sustituida en posición 5, 6 o 7 y uso terapeutico del mismo. | |
TW200633987A (en) | Phenylpiperazines with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sites | |
WO2005097757A3 (en) | Nucleoside derivatives and therapeutic use thereof | |
WO2007109871A3 (en) | Acridine derivatives with antitumoral activity | |
WO2007079929A3 (de) | Substituierte tricyclische piperidon-derivate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20200605 |